Search

The purpose of this study was to evaluate the diagnostic performance of a hand-held electronic glucometer (Precision Xtra; Abbott Diabetes Care Inc., Mississauga, ON, Canada) for cow-side use in dairy cattle. This device has been validated for measuring blood concentrations of β-hydroxybutyrate in dairy cows. This study was designed to assess the accuracy of whole-blood glucose measurements from the glucose meter relative to a reference chemical analyzer in a diagnostic laboratory. Duplicate samples were taken from the same cows at the same time, into blood tubes with either the glycolysis-inhibiting preservative sodium fluoride (NaF) or without preservative. Glucometer readings were taken on whole blood with no preservative, and laboratory measurements were conducted on serum preserved with NaF. Blood samples were collected from cows between 3 wk before and 5 wk after calving, including during a glucose tolerance test conducted 1 wk before expected calving. Passing-Bablok and Bland-Altman data analyses were used to evaluate the performance of the glucometer relative to the laboratory results. A strong correlation was observed in 709 samples from 81 cows between the hand-held meter and serum from samples preserved with NaF (R² = 0.95). Overall, 96% of measurements with the glucometer fell within the 95% confidence limits of analysis in the laboratory, although at higher-than-physiologic glucose concentrations (>5.2 mmol/L) the glucometer tended to overestimate. The hand-held glucometer appears suitable for rapid measurement of glucose under field conditions in dairy cattle. [ABSTRACT FROM AUTHOR]

The objectives were to identify risk factors for and to quantify the effect of postpartum anovulation on reproductive performance in dairy cows. Data from 2,178 Holstein cows in 6 commercial herds enrolled in a randomized clinical trial were used. Data on periparturient disease incidence, calving history, and body condition score were collected. Cows were examined at wk 5 postpartum for reproductive tract disease; cytological endometritis was defined as ≥6% polymorphonuclear cells in endometrial cytology, and purulent vaginal discharge was defined as the presence of mucopurulent or purulent vaginal discharge. Cows were followed until 300 d in milk (DIM) for reproductive performance. Serum nonesterified fatty acids (NEFA) concentration was measured once during the week before expected calving. Serum β-hydroxybutyrate, NEFA, and haptoglobin were measured at wk 1, 2, and 3 postpartum. Serum progesterone (P4) was measured at wk 3, 5, 7, and 9 postpartum. The end of the postpartum anovulation period was defined as the first sampling time at which P4 was >1 ng/mL. Statistical analyses were performed using logistic regression models and Cox proportional hazard models. The prevalence of anovulation was 72, 44, 26, and 17% at wk 3, 5, 7, and 9, respectively. Cows were classified according to their ovulatory status as having luteal function at 21 DIM (Cyc21), as having low P4 at 21 DIM but having luteal function at least once at 35 or 49 or 63 DIM (Cyc63), or being anovulatory at 63 DIM (Anov63; no samples with P4 >1 ng/ mL). Factors associated with early ovulation (Cyc21) included season, parity, decreased haptoglobinemia, and decreased serum NEFA concentration before and after parturition. Risk factors for prolonged anovulation (Anov63) included cytological endometritis, increased haptoglobinemia, and greater serum NEFA concentrations before and after parturition. Cows classified as Anov63 had an increased median time to first breeding compared with Cyc63 (74.1 vs. 73.2 d). The effect of prolonged postpartum anovulation on median time to pregnancy was conditional on parity group; a detrimental effect was present in cows of parity ≥3 (129 d for Cyc21, 151 d for Cyc63, and 180 d for Anov63), but no effect was observed in cows of parity ≥2. Overall, these findings suggest that postpartum anovulation was associated with indicators of energy balance and uterine inflammation, and with detrimental effects on reproductive performance. [ABSTRACT FROM AUTHOR]

Data from 1,010 lactating lactating, predominately component-fed Holstein cattle from 25 predominately tie-stall dairy farms in southwest Ontario were used to identify objective thresholds for defining hyperketonemia in lactating dairy cattle based on negative impacts on cow health, milk production, or both. Serum samples obtained during wk 1 and 2 postpartum and analyzed for β-hydroxybutyrate (BHBA) concentrations that were used in analysis. Data were time-ordered so that the serum samples were obtained at least 1 d before the disease or milk recording events. Serum BHBA cutpoints were constructed at 200 µmol/L intervals between 600 and 2,000 l, mol/L. Critical cutpoints for the health analysis were determined based on the threshold having the greatest sum of sensitivity and specificity for predicting the disease occurrence. For the production outcomes, models for first test day milk yield, milk fat, and milk protein percentage were constructed including covariates of parity, precalving body condition score, season of calving, test day linear score, and the random effect of herd. Each cutpoint was tested in these models to determine the threshold with the greatest impact and least risk of a type 1 error. Serum BHBA concentrations at or above 1,200 µmol/L in the first week following calving were associated with increased risks of subsequent displaced abomasum [odds ratio (OR) = 2.60] and metritis (OR = 3.35), whereas the critical threshold of BHBA in wk 2 postpartum on the risk of abomasal displacement was ≥1,800 µmol/L (OR = 6.22). The best threshold for predicting subsequent risk of clinical ketosis from serum obtained during wk 1 and wk 2 postpartum was 1,400 µmol/L of BHBA (OR = 4.25 and 5.98, respectively). There was no association between clinical mastitis and elevated serum BHBA in wk 1 or 2 postpartum, and there was no association between wk 2 BHBA and risk of metritis. Greater serum BHBA measured during the first and second week postcalving were associated with less milk yield, greater milk fat percentage, and less milk protein percentage on the first Dairy Herd Improvement test day of lactation. Impacts on first Dairy Herd Improvement test milk yield began at BHBA ≥1,200 µmol/L for wk 1 samples and ≥1,400 µmol/L for wk 2 samples. The greatest impact on yield occurred at 1,400 µmol/L (-1.88 kg/d) and 2,000 µmol/L (-3.3 kg/d) for sera from the first and second week postcalving, respectively. Hyperketonemia can be defined at 1,400 µmol/L of BHBA and in the first 2 wk postpartum increases disease risk and results in substantial loss of milk yield in early lactation. [ABSTRACT FROM AUTHOR]

A meta-analysis of the impact of monensin on health and reproductive outcomes in dairy cattle was conducted. A total of 16 papers were identified with sufficient data and quality to evaluate health and reproductive outcomes for monensin. The available trials provided approximately 9,500 cows with sufficient data for analysis. This provided good statistical power to examine the effects of monensin on health and reproduction. Over all the trials analyzed, monensin decreased the risk of ketosis [relative risk (RR) = 0.75], displaced abomasums (RR = 0.75), and mastitis (RR = 0.91). No significant effects of monensin were found for milk fever, lameness, dystocia, retained placenta, or metritis. Monensin had no effect on first-service conception risk (RR = 0.97) or days to pregnancy (hazard ratio = 0.93). However, the impact of monensin on dystocia, retained placenta, and metritis was heterogeneous for all 3 outcome measures and random effect models were utilized. Causes of the heterogeneity were explored with meta-regression. Days of treatment with monensin before calving increased the risk of dystocia. Delivery method of monensin influenced the incidence of retained placenta and metritis, with risk being lower with controlled release capsule treatment compared with delivery in either topdress or in a total mixed ration. Days of treatment before calving also influenced retained placenta with an increase in risk with more days treated before calving. Improvements in ketosis, displaced abomasums, and mastitis with monensin were achieved. Exposure to prolonged treatment in the dry period with monensin may increase the risk of dystocia and retained placenta. [ABSTRACT FROM AUTHOR]

A meta-analysis of the impact of monensin on metabolism of dairy cattle was conducted following a search of the literature. A total of 59 studies with monensin feeding in dairy cattle were identified in which 30 papers and 45 trials contained metabolic data. The phydroxybutyrate (BHBA) data were obtained from over 4,000 cows and 115 trial sites. Data for each trial were extracted and analyzed using meta-analysis software in Stata. Estimated effect sizes of monensin were calculated on blood concentrations of BHBA, acetoacetate, nonesterified fatty acids (NEFA), glucose, cholesterol, urea, calcium, insulin, and milk urea. Monensin use in lactating dairy cattle significantly reduced blood concentrations of BHBA 13%, acetoacetate 14%, and NEFA 7%. Monensin increased glucose 3% and urea 6%. Monensin had no significant effect on cholesterol, calcium, milk urea, or insulin. Heterogeneity was significant for BHBA and cholesterol [I2 (measure of variation beyond chance) = 37 and 54%, respectively]; therefore, random effects models were used for those analytes. Publication bias existed with the monensin effect on BHBA, with a tendency for studies to be published if there was a significant reduction in this ketone. Meta-regression analysis of the effect sizes obtained from the metabolic data showed that method of delivery, timing of administration, stage of lactation, and diet were influential in modifying effect size of monensin treatment. Use of top dress or delivery via a controlled release capsule reduced the magnitude of effect on BHBA (coefficient +0.353); however, top dress use compared with controlled release capsule or total mixed ration enhanced the monensin effect on glucose (coefficient +0.296). There was a greater impact with monensin on reducing BHBA in early lactation (coefficient -0.151) and in pasture-based trials (coefficient -0.194). Use of monensin in both the pre- and postcalving periods was associated with an enhanced impact on NEFA (coefficient -0.254). Monensin had less impact on serum glucose in the precalving time period (coefficient -0.237). These findings demonstrate an improvement in the energy metabolism of dairy cows supplemented with monensin. [ABSTRACT FROM AUTHOR]

A meta-analysis of the impact of monensin on production outcomes in dairy cattle was conducted using the 36 papers and 77 trials that contained eligible data. Statistical analyses were conducted in STATA and included a consideration of fixed or random effects models, assessment of publication bias, and impact of influential studies. Meta-regression was used to investigate sources of heterogeneity of response. There were 71 trials containing data from 255 trial sites and 9,677 cows examining milk production and composition. Monensin use in lactating dairy cattle significantly decreased dry matter intake by 0.3 kg, but increased milk yield by 0.7 kg and improved milk production efficiency by 2.5%. Monensin decreased milk fat percentage 0.13%, but had no effect on milk fat yield; however, there was significant heterogeneity between studies for both of these responses. Milk protein percentage was decreased 0.03%, but protein yield was increased 0.016 kg/d with treatment. Monensin had no effect on milk lactose percentage. Monensin increased body condition score by 0.03 and similarly improved body weight change (0.06 kg/d). Analysis of milk fatty acid profile data indicated that monensin was associated with a reduction of short-chain fatty acids (from 1 to 12% reduction) and stearic acid (-7.8%). The impact of monensin on linoleic and linolenic acids was variable, but monensin significantly increased conjugated linoleic acid (22%). Meta-regression of the effect of monensin on milk component percentages and yields indicated an influence of delivery method, stage of lactation, dose, and diet. Increasing concentrations of C18:1 in the diet enhanced the effect of monensin on decreasing milk fat yield, whereas increasing the rumen peptide balance increased the effect of monensin on milk protein yield. These findings indicate a benefit of monensin for improving milk production efficiency while maintaining body condition. The effect of monensin on milk fat percentage and yield was influenced by diet. [ABSTRACT FROM AUTHOR]

Choline and monensin may be supplemented during the transition period with the objectives of aiding in fat metabolism and improving energy balance, respectively. The objectives of this study were to determine the effects of supplementing rumen-protected choline (RPC) and monensin in a controlled-release capsule (CRC) on metabolism, dry matter intake, milk production, and liver function in transition dairy cattle. Three weeks before expected calving, 182 Holsteins were randomly assigned to receive one of the following: a monensin CRC, 56 g/d of RPC until 28 d in milk, CRC + RPC, or neither supplement (control). Blood samples were collected at enrollment, 1 wk before calving, and in the first and second weeks after calving. Liver biopsies were obtained from multiparous cows randomly selected from each treatment group within 24 h and again 3 wk postpartum. Daily milk production was recorded through 60 d in milk. There were no interactions of the effects of RPC and CRC on any of the outcomes measured. Overall, cows that received RPC produced 1.2 kg/d more milk in the first 60 d of lactation, but this effect was attributable to an increase in milk production of 4.4 kg/d among cows with a body condition score ≥4 at 3 wk before calving; fat cows that received RPC ate 1.1 kg of DM/d more from wk 3 before calving through wk 4 after calving. Monensin supplementation significantly increased serum concentrations of glucose and urea, lowered concentrations of β-hydroxybutyric acid and aspartate aminotransferase in the peripartum period, and increased liver glycogen content at 3 wk into lactation. The metabolic effects of CRC are consistent with previous studies, and the effects on liver are novel. The mechanism by which RPC increased milk production was not revealed in this study and merits further research. [ABSTRACT FROM AUTHOR]

The objective of this study was to determine the effect of milking frequency on the behavioral patterns and productivity of lactating dairy cows. Twelve freestall-housed, lactating Holstein dairy cows (7 primiparous and 5 multiparous) were exposed to each of 2 treatments (over 21-d periods) in a replicated crossover design. Treatments were milking frequency of 2x/d (at 0600 and 1800 h) or 3x/d (at 0600, 1400, and 2200 h). Milk production, feeding, lying, and rumination behavior were monitored for each animal for the last 7 d of each treatment period. Milk samples were collected for the last 3 d of each period for milk component analysis. The results indicated that cows milked 3x/d produced 2.9 kg/d more milk than those milked 2x/d. Primiparous cows consumed 3.9 kg/d less dry matter (DM) than did multiparous cows. The extra time (14.6 min/d) required for milking 3x/d altered the distribution of cow behavioral activity throughout the day. Although this did not affect total daily lying or rumination time, we observed a tendency for cows milked 2x/d to spend less time (224.6 vs. 237.5 min/d) feeding and, thus, those cows tended to consume their feed at a faster rate (0.13 vs. 0.12 kg of DM/min) than cows milked 3x/d. For multiparous cows, the increase in feeding activity was facilitated through having longer (40.1 vs. 36.8 min/meal) and numerically larger meals (4.8 vs. 4.6 kg of DM/meal) when milked 3x/d. Alternatively, primiparous cows consumed smaller (2.9 vs. 3.2 kg of DM/meal) and more frequent meals (9.1 vs. 7.7 meals/d) throughout the day when milked 3x/d, resulting in a tendency for greater DM intake (24.7 vs. 23.6 kg/d) compared with primiparous cows milked 2x/d. These results indicate that under 3x/d milking schedules, primiparous cows will positively adjust their feeding behavior to achieve similar production increases as multiparous cows. In summary, milking 3x/d can be used to improve production; however, greater milking frequency elicits varying effects on the behavior of primiparous and multiparous cows, suggesting that grouping and management of cows based on parity may be beneficial. [ABSTRACT FROM AUTHOR]

Neospora caninum has been reported to be an important cause of endemic fetal loss and occasional abortion epidemics in cattle around the world. This study examined 12,016 sera collected from 9723 Holstein cows on 125 herds across Ontario in 1998, 1999, and 2000. An enzyme-linked immunosorbent assay was used to examine the sera for antibodies to N. caninum. The overall prevalence of N. caninum antibodies in the cattle was 11.2% and the prevalence in individual herds varied from 0 to 70.4%. Among 3109 daughter-dam pairs, 619 positive dams had 252 positive daughters, giving a detected vertical transmission rate of 40.7%. In contrast, there were only 6.7% positive daughters from negative dams (167 of 2490). Pedigree edits left 8031 cows with 1463 sires for estimation of heritability. Five genetic models (sire model, animal model, siredam model, a sire-maternal grandsire model, and a maternal effects model) with fixed effects of bleeding year-month, age of the animals, and herd were fitted to the data. The estimated heritability of susceptibility to N. caninum ranged between 0.084 and 0.124. The sire-maternal grandsire model and the maternal effects model provided better fit than the other models because the maternal genetic variance was much greater than the direct genetic variance. To reduce the incidence of N. caninum infection, more emphasis should be placed on management practices than on genetic selection. [ABSTRACT FROM AUTHOR]

Research on the assessment and management of pain in cows following difficult or assisted calving is still limited, especially on the effects of analgesics intended to mitigate this pain. The purpose of this study was to assess the effects of flunixin meglumine on the health and production of Holstein cows after calving. In total, 34 flunixin-treated and 38 placebo-treated animals were enrolled in a precalving treatment trial. A total of 633 animals given flunixin and 632 animals administered a placebo were enrolled in a postcalving treatment trial. In both cases, animals were randomly assigned to treatment, and researchers were blind to treatment condition until after analysis. A total of 1,265 animal records were analyzed for milk production for the first 14 d in milk and health outcomes for the first 30 d in milk. Animals treated with flunixin meglumine before calving had a significantly increased risk of stillbirth. Animals treated immediately after calving had increased odds of having a retained placenta and, in turn, increased risk of a high temperature, decreased milk production, and an increased risk of developing metritis. The administration of flunixin meglumine within 24 h of parturition is not recommended in dairy cattle. [ABSTRACT FROM AUTHOR]

The objective of this study was to characterize the relationship between rumination and subclinical ketosis (SCK) in transition dairy cows. A study was conducted on 4 commercial dairy farms in eastern Ontario, Canada. A total of 339 Holstein dairy cows (107 primiparous and 232 multiparous) were monitored for rumination activity and SCK from 14 d before calving until 28 d after calving. Rumination was recorded daily using an automated monitoring system. A blood sample was taken from the coccygeal vein of each cow for measurement of β-hydroxybutyrate (BHB) once weekly throughout the 6-wk observation period. Cows with BHB ⩾1.2 mmol/L in any of the 4 postpartum samples were considered to have SCK. Cases of retained placenta, metritis, milk fever, or mastitis during the study period were also recorded. Cows were categorized into 1 of 4 groups: healthy cows (HLT) that had no SCK or any other recorded health problem (n = 139); cows treated for at least one health issue other than SCK (HLT+; n = 50); cows with SCK (hyperketonemia; HYK) with no other health problems during transition (n = 97); or cows (HYK+) that had SCK and one or more other health problems (n = 53). Daily rumination time was summarized by week and comparisons were made between HLT and HYK and HYK+. From 2 wk before calving (wk -2) to 4 wk after calving (wk +4), there was no difference in rumination time (409 ± 9.8 min/d) among HLT, HYK, and HYK+ cows in their first lactation. Multiparous cows in HLT spent an average of 459 ± 11.3 min/d ruminating from wk -2 to wk +4. Multiparous HYK cows ruminated 25 ± 12.8 min/d less than HLT cows, whereas HYK+ cows ruminated 44 ± 15.6 min/d less than HLT cows. The largest differences in rumination time between HLT and HYK+ cows were seen during wk -1, +1, and +2, when HYK+ cows ruminated 48 ± 17.2, 73 ± 16.0, and 65 ± 19.4 min/d less than HLT cows, respectively. In multiparous cows, increased odds of HYK were associated with greater milk yield in the previous lactation, greater loss of body condition over the transition period, greater stall stocking density in wk -1, and reduced rumination time in wk -1. Increased odds of HYK+ were associated with higher parity, longer dry period, greater stall stocking density in wk -1, and reduced rumination time in wk +1. These results suggest that rumination monitoring across the transition period might contribute to identification of SCK and other health problems in multiparous cows. [ABSTRACT FROM AUTHOR]

The effect of administering recombinant bovine somatotropin (rbST) to cows with hyperketonemia during the early postpartum period on health, metabolic parameters, milk production, and early reproductive performance was evaluated in a double-blinded clinical trial. Cows from 8 dairy herds in New York State were tested weekly between 3 and 16 d in milk for elevated serum β-hydroxybutyrate. Cows were enrolled in the study when blood β-hydroxybutyrate was ≥1.3 mmol/L for the first time. Enrolled cows were randomly assigned to a treatment (n = 273) or placebo control (n = 270) group. Treated cows were given 325 mg of rbST subcutaneously on the day of enrollment and again 14 d later. Control cows received the same regimen except the syringe contained only the carrier without somatotropin. After enrollment, blood samples were collected weekly for 4 wk and submitted to the laboratory to be analyzed for selected metabolites. Risk ratios for clinical diseases subsequent to treatment were calculated using Poisson regression. Continuous data were analyzed using linear mixed models. Time to first insemination was assessed with survival analysis. In the 42 d following the first administration of rbST, incidence risks of displaced abomasum, clinical ketosis, metritis, clinical mastitis, and lameness were not different between treatment groups. Cows treated with rbST had a slightly lower body condition score 28 d after enrollment compared with control cows. In the 4 wk following enrollment, serum nonesterified fatty acids and aspartate amino-transferase were slightly higher for treated than control cows, respectively. Serum glucose, calcium, haptoglobin, and β-hydroxybutyrate were similar between groups. Treatment had no effect on resolution of hyperketonemia in any of the 4 wk after enrollment. Milk production in either of the 2-wk periods after each treatment was not different between treated and control cows. Furthermore, milk production was not different between groups from enrollment to 98 d in milk (42.6 ± 0.6 and 42.1 ± 0.7 kg/d for treatment and control groups, respectively). Treatment had no effect on time to first insemination (83 and 74 d in milk for treatment and control groups, respectively; hazard ratio = 0.72) or first insemination pregnancy risk (27 and 29% for treatment and control groups, respectively; risk ratio = 0.92). Based on the current results, it is not recommended to use a low dose of rbST as therapy for cows with hyperketonemia. [ABSTRACT FROM AUTHOR]

Two studies were conducted. The objective of the first study was to assess the effects of a direct-fed microbial (DFM) product on dry matter intake, milk yield, milk components, disease incidence, and blood metabolites in dairy cattle. The objective of the second study was to assess the effects of DFM on apparent total-tract nutrient digestibility (ATTD). One hundred twenty primiparous and multiparous Holstein cows housed in a tiestall facility at the University of Guelph were used in study 1, and a subset (21) of the same cows participated in study 2. Cows were blocked by anticipated calving date (6 blocks) and then randomly assigned within parity to receive either a DFM supplement (Chr. Hansen Ltd., Milwaukee, WI) or placebo (control). The DFM supplement provided cows with 5.0 x 109 cfu/d of 3 strains of Enterococcus faecium and 2.0 x 109 cfu/d of Saccharomyces cerevisiae. The DFM supplement was mixed with 0.5 kg of ground dry corn and top-dressed during the morning feeding. The placebo supplement contained the corn only. Individual feed intakes and milk yields were recorded daily. The experiment commenced 3 wk before calving and ended 10 wk postcalving. Milk samples for component analysis were collected on 3 d per week and pooled by week. Body weights and body condition scores were assessed 1 d before enrollment in the study (wk -3), postcalving (wk 1), and at the end of wk 3, 6, and 9. Blood samples were collected before calving (wk-3) and the end of wk 1 and 3. Study 1 showed that treatment had no effect on average dry matter intake or milk yield (kg/d) over the duration of the experiment. The changes in body weights and body condition scores and net energy balance over the duration of the experiment did not differ due to treatment. Treatment had no effect on plasma concentrations of β-hydroxybutyrate, non-esterified fatty acids, glucose, or haptoglobin. Study 2 investigated the effects of DFM on ATTD of starch and neutral detergent fiber (NDF) using insoluble NDF and lignin as internal markers. Study 2 used 21 cows (block 6) from the cows that participated in study 1 while the cows were between 60 and 70 d in milk. Cows receiving DFM had lower fecal starch content (0.88 ± 0.10 vs. 1.39 ± 0.25) and greater ATTD for starch (98.76% ± 0.28 vs. 97.87% ± 0.24) compared with those receiving placebo, and the AATD of NDF did not differ. Additionally, we detected no difference between internal markers for the measurement of ATTD. In conclusion, we were unable to detect a change in overall dry matter intake, milk yield, or milk and blood parameters with DFM supplementation. However, our results demonstrated that DFM can have a positive effect on total-tract starch digestibility. More studies are needed to investigate the effects of DFM and their modes of action under multiple management conditions. [ABSTRACT FROM AUTHOR]

A double-blind, randomized clinical trial was conducted in 5 commercial dairy herds in southern Ontario with 1,362 cows enrolled to evaluate the effect of prepartum administration of recombinant bovine somatotropin (rbST) on health and performance. Cows were randomly assigned to receive either 325 mg of sometribove zinc suspension (n = 680) or a placebo injection (n = 682; control) subcutaneously every 14 d until calving. Treatments started 28 to 22 d before expected calving, with a maximum of 3 treatments per cow. Serum samples taken at the time of enrollment, 1 wk before calving, and weekly for 3 wk after calving were analyzed for nonesterified fatty acids (NEFA), β-hydroxybutyrate (BHBA), glucose, aspartate aminotransferase, calcium, and haptoglobin. Diseases were recorded by farm staff. Incidences of clinical ketosis, clinical mastitis, displaced abomasum, metritis, retained placenta, milk fever, and lameness were similar between groups. Body condition score was lower for treated than for control cows at 3 wk after calving (3.13 and 3.17, respectively). Serum NEFA tended to be higher for treated than for control cows by 0.01 mmol/L. Overall BHBA was not different between groups, but BHBA for treated cows was higher in wk 1 after calving (750 and 698 μmol/L, respectively) and tended to be higher in wk 2 after calving (779 and 735 μmol/L, respectively). Incidence of hyperketonemia was similar between groups. Treated cows had higher serum glucose compared with control cows (2.8 and 2.7 mmol/L, respectively). We detected no differences in serum aspartate aminotransferase, calcium, or haptoglobin between groups. Milk yield was recorded daily for each cow for 63 d, and did not differ between groups (37.1 ± 0.5 kg and 36.7 ± 0.5 kg, respectively) but we detected a tendency for treated cows to produce 0.8 kg/d more milk than control cows in wk 1 after calving. We observed no difference between groups in the time from calving to first insemination or the probability of pregnancy at the first insemination. Groups did not differ in the proportion of anovular cows at 53 ± 3 d in milk based on serum progesterone measured from a subset of cows (38.0 and 34.3%, respectively, for treated and control groups). We found no difference between groups in dry matter intake from 21 d before calving to 63 d after calving in a subset of cows (17.4 ± 0.4 and 17.5 ± 0.4 kg/d, respectively). Based on results of the current study, biweekly (every 14 d) administration of rbST before calving to prevent disease and enhance performance is not recommended. [ABSTRACT FROM AUTHOR]

The objective of this study was to validate the efficacy of a radiotelemetric bolus (RTB) to detect changes in ruminal temperature resulting from (1) systemic illnesses that are associated with febrile responses and (2) subacute ruminal acidosis (SARA). Eight rumenfistulated, lactating Holstein cows (586 ± 37 kg of body weight, 106 ± 18 d in milk) were used in a replicated 4 x 4 Latin square design with a 2 x 2 factorial arrangement. Each period consisted of 21 d. The factors were 2 diets, a moderate forage:concentrate [MFC; 52:48; % of dry matter (DM)] or a high forage:concentrate (HFC; 65:35, % of DM) total mixed ration, and a challenge with a single intramammary injection of lipopolysaccharide (LPS; 100 µg derived from Escherichia coli 0111:B4) or no LPS (sterile saline). Thus, the 4 resulting treatments were (1) MFC with LPS challenge, (2) MFC with saline, (3) HFC with LPS challenge, and (4) HFC with saline. Cows were fed at 0800 and 1400 h daily. Cows received the intramammary injections at 0900 h of d 21. Ruminal pH and ruminal temperature were also measured on d 21 every minute via an indwelling logging system that resided in the ventral sac of the rumen and via a radiotelemetric bolus that resided in the reticulum. Vaginal temperature was also recorded every minute via temperature loggers. Prior to LPS injection, the duration of rumen pH below 5.6 (indicative of SARA) was higher in cows receiving MFC than cows receiving HFC (148 ± 24 and 62 ± 24 min/d, respectively). The temperature measured at the same time via RTB was higher for MFC than HFC cows (167 ± 21 vs. 104 vs. 21 min/d above 38.8°C, respectively). The following day, cows challenged with LPS showed signs of mastitis within the injected quarters, depressed DM intake, decreased milk yield, and a peak vaginal temperature of 41.3 ± 0.1°C 5.5 h after the LPS injection. The RTB system successfully detected a fever response parallel to that measured by the vaginal loggers but temperature peak detected by RTB was, on average, 0.5°C lower than that detected by the vaginal logger. Although the RTB system was able to detect a temperature response to the diet effect before LPS challenge, it was unable to detect this effect during the LPS challenge, likely because cows receiving the LPS challenge had decreased feed consumption. In conclusion, radiotelemetry has the potential to improve the detection of SARA and fever on farm. [ABSTRACT FROM AUTHOR]

The objective of this study was to investigate the effect of monensin (MN) and dietary soybean oil (SBO) on milk fat percentage and milk fatty acid (FA) profile. The study was conducted as a randomized complete block design with a 2 x 3 factorial treatment arrangement using 72 lactating multiparous Holstein dairy cows (138 ± 24 d in milk). Treatments were [dry matter (DM) basis] as follows: 1) control total mixed ration (TMR, no MN) with no supplemental SBO; 2) MN-treated TMR (22 g of MN/kg of DM) with no supplemental SBO; 3) control TMR including 1.7% SBO; 4) MN-treated TMR including 1.7% SBO; 5) control TMR including 3.4% SBO; and 6) MN-treated TMR including 3.4% SBO. The TMR (% of DM; corn silage, 31.6%; haylage, 21.2%; hay, 4.2%; high-moisture corn, 18.8%; soy hulls, 3.3%; and protein supplement, 20.9%) was offered ad libitum. The experiment consisted of a 2-wk baseline, a 3-wk adaptation, and a 2-wk collection period. Monensin, SBO, and their interaction linearly reduced milk fat percentage. Cows receiving SBO with no added MN (treatments 3 and 5) had 4.5 and 14.2% decreases in milk fat percentage, respectively. Cows receiving SBO with added MN (treatments 4 and 6) had 16.5 and 35.1% decreases in milk fat percentage, respectively. However, the interaction effect of MN and SBO on fat yield was not significant. Monensin reduced milk fat yield by 6.6%. Soybean oil linearly reduced milk fat yield and protein percentage and linearly increased milk yield and milk protein yield. Monensin and SBO reduced 4% fat-corrected milk and had no effect on DM intake. Monensin interacted with SBO to linearly increase milk fat concentration (g/100 g of FA) of total trans-18:l in milk fat including trans-6 to 8, trans-9, trans-10, trans-11, trans-12 18:1 and the concentration of total conjugated linoleic acid isomers including cis-9, trans-11 18:2; trans-9, cis-11 18:2; and trans-10, cis-12 18:2. Also, the interaction increased milk concentration of polyunsaturated fatty acids. Monensin and SBO linearly reduced, with no significant interaction, milk concentration (g/100 g of FA) of short- and medium -chain fatty acids (

The objective of this study was to evaluate the effects of level of concentrate acidogenic value (AV) and forage particle size on ruminal pH and feed intake in lactating dairy cows. Two isoenergetic (net energy for lactation = 1.5 ± 0.01 Mcal/kg) and isonitrogenous (crude protein = 17.4 ± 0.1% dry matter) concentrates with either a low AV or high AV were formulated and fed in a total mixed ration with either coarsely or finely chopped corn silage and alfalfa haylage ad libitum. Four rumen-fistulated cows (114 ± 14 d in milk) were randomly assigned to 1 of the 4 treatments in a 4 x 4 Latin square with a 2 x 2 factorial treatment arrangement. Each period consisted of 3-wk (14-d treatment adaptation and 7-d data collection). Increasing the concentrate AV decreased the mean pH (from 6.07 to 5.97) and minimum pH (from 5.49 to 5.34). Cows fed high-AV diets spent a longer time below pH 5.6 (135.1 vs. 236.7 min/d; low-AV diet vs. high-AV diet, respectively) and pH 5.8 (290.0 vs. 480.6 min/d; low-AV diet vs. high-AV diet, respectively) than cows fed low-AV diets. Increasing forage particle size had no effect on the mean and minimum ruminal pH. There was an interaction between concentrate AV and forage particle size on maximum ruminal pH. Increasing forage particle size increased the maximum pH for cows fed the high-AV concentrate (6.69 vs. 6.72; low-AV diet vs. high-AV diet, respectively) and had no effect on the maximum pH for cows fed the low-AV concentrate (6.98 vs. 6.76; low-AV diet vs. high-AV diet, respectively). Increasing the concentrate AV did not affect dry matter intake but reduced neutral detergent fiber intake from 9.7 to 8.8 kg/d. Milk fat content was negatively correlated with time and area below pH 5.6 (time below, r = -0.51; area below, r = -0.56) and pH 5.8 (time below, r = -0.42; area below, r = -0.54). These results suggest that coarse forage particle size can attenuate drops in ruminal pH. However, the ameliorating effects of forage particle size on drops in ruminal pH were more apparent for high-AV diets than for low-AV diets. The AV approach combined with physically effective neutral detergent fiber would therefore improve the formulation of diets and help to mitigate subacute ruminal acidosis in dairy cows. [ABSTRACT FROM AUTHOR]

This paper describes some of the major points of progress and challenges in health management of dairy cattle in the last 25 yr. A selection of the leading contributors in the field is acknowledged. Specific advances in the areas of transition cow management, epidemiology, udder health, applied immunology, housing design, calf health, and health-monitoring tools are described. The greatest advances in dairy health in the last 25 yr have been the shifts to disease prevention, rather than treatment, as well as from focus on individual animals to groups and herds. A fundamental advancement has been recognition of the multifactorial nature of almost all diseases of importance in dairy cattle. Epidemiology has been a critical new tool used to describe and quantify the interconnected risk factors that produce disease. Another major advance has been redefining disease more broadly, to include subclinical conditions (e.g., subclinical mastitis, ketosis, rumen acidosis, and endometritis). This expansion resulted both from improved technology to measure function at the organ level and, just as importantly, from the evolution of the health management paradigm in which any factor that limits animal or herd performance might be considered a component of disease. Links between cattle and people through consideration of environmental or ecosystem health are likely to further expand the concept of disease prevention in the future. Notable successes are decreases in the incidence of milk fever, clinical respiratory disease in adults, contagious mastitis, and clinical parasitism. There has also been improved protection through vaccination against coliform mastitis and bovine virus diarrhea. Since 1980, average herd size and milk production per cow have increased dramatically. Despite these increased demands on cows' metabolism and humans' management skills, the incidence of most common and important diseases has remained stable. Great progress has been made in understanding the biology of energy metabolism and immune function in transition dairy cows, the time at which the majority of disease occurs. Coupled with an emerging understanding of how best to provide for dairy cows' behavioral needs, transition cow management promises to be the foundation for progress in maintenance and enhancement of the health of dairy cows in the next 25 yr. [ABSTRACT FROM AUTHOR]

Effects of prepartum administration of a monensin controlled release capsule (CRC) and stage of lactation on variation of blood metabolites within 24 h were determined in 16 dairy cows. Cows were fed a total mixed ration ad libitum twice daily at 0700 and 1300 h. At calving, cows were switched from a close-up dry cow diet to a lactating cow diet. Cows were blood sampled every 3 h for 24 h at 3 stages of lactation, including 1 wk before calving (wk -1), 1 wk after calving (wk 1), and 6 wk after calving (wk 6). Serum concentrations of glucose, β-hydroxybutyrate (BHBA), nonesterified fatty acids (NEFA), and urea exhibited significant variation within 24 h. Glucose and NEFA were, respectively, 0.09 and 0.08 mM lower between 1030 and 2230 h than between 2230 and 1030 h. β-Hydroxybutyrate and urea were, respectively, 95.1 and 0.49 mM higher between 1030 and 2230 h than between 2230 and 1030 h. Monensin did not significantly affect glucose, NEFA, and urea in this study. Monensin reduced BHBA at wk 1, but not at wk -1 or wk 6. Glucose was lower and BHBA and NEFA were higher at wk 1 compared with wk -1 and wk 6. Urea was higher at wk 6 compared with wk -1. The variation within 24 h of glucose, BHBA, and NEFA were not affected by monensin and stage of lactation. Diurnal variation of urea was affected by stage of lactation, but not by monensin. [ABSTRACT FROM AUTHOR]

Four multiparous ruminally fistulated Holstein dairy cows were used in an 8-wk experiment utilizing a repeated measures block design to determine the effects of subacute ruminal acidosis (SARA) on supplemented water intake. Animals were subjected to SARA, which was induced by replacing 25% of the ad libitum intake of the total mixed ration (dry matter basis) with 50:50 wheat:barley pellets utilizing a grain challenge model. Cows had free choice from 2 water bowls. One bowl contained water with sodium bicarbonate (SB) supplemented at 2.5 g/L. The other bowl contained unsupplemented water. Ruminal pH was monitored continuously during the trial using indwelling pH probes. The induction of SARA reduced daily mean ruminal pH and increased the duration when ruminal pH was below 6. The total mixed ration intake by the cows decreased during the SARA periods. The overall preference for SB supplemented water did not change, as the preference ratio was similar during the control and SARA periods. During the period of greatest ruminal pH depression, total water intake was higher during the SARA periods than during the control periods. During SARA, there was no difference in the preference of a SB water source to unsupplemented water. During the period of day with the most severe ruminal pH depression, the lactating dairy cows subjected to SARA increased their total water intake. [ABSTRACT FROM AUTHOR]